Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05942248

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Integrative Skin and Research

Sacramento, California, 95815, United States

Location status: Recruiting

Location contact

Raja Sivamani, MD, MS, AP

CONTACT

[email protected]

916-750-2463

About this study

The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to dermatologist based clinical severity grading.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults with acne, rosacea, melasma or seborrheic dermatitis

Exclusion criteria

  • Prisoners
  • Adults unable to consent
  • Artificial facial markings on day of facial photography (such as piercings and tattoos) that may interfere with imaging in the opinion of the investigator

Treatment and study plan

No intervention

Other

No Intervention

Primary outcomes

  1. Correlation of image-based grading to clinical gradings for acne

    Time frame: Baseline

    Number of inflammatory and noninflammatory lesions compared to clinical grading

  2. Correlation of image-based grading to clinical gradings for rosacea

    Time frame: Baseline

    Inflammatory lesion count compared to clinical grading

  3. Correlation of image-based grading to clinical gradings for melasma

    Time frame: Baseline

    Melasma area severity index image based grading compared to clinical grading

  4. Correlation of image-based grading to clinical gradings for seborrheic dermatitis

    Time frame: Baseline

    Seborrheic dermatitis area severity index

Secondary outcomes

  1. Sebum excretion rate

    Time frame: Baseline

    Measure of skin sebum via sebumeter

Study contacts

Contact information is provided by the study sponsor or research team.

Raja Sivamani, MD, MS, AP

CONTACT

[email protected]

916-750-2463

Sponsors and collaborators

Lead sponsor

Integrative Skin Science and Research

Industry

Collaborators

  • Codex Labs

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Jul 12, 2023
Registry last updated
Aug 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.